Chase AIBulk Dataset ExportPricingFAQsBlog
Display currency
Loading news…

Amgen

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Thousand Oaks, California, United States Founded 1980 10001+ employees For Profit
Website LinkedIn Twitter

Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases.

Amgen on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.

BiotechnologyHealth CareManufacturingPharmaceutical
Total Funding
$28.5B
Funding Rounds
1
Last Funding
Acquisitions
26
Investments
19
11 exits
Monthly Visits
Contacts
5,271
Ticker
AMGN
NASDAQ
Patents
3,002
384 trademarks

About Amgen

Funding & Financials

Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Public
Ticker
AMGN
Exchange
NASDAQ
IPO date
Jun 17, 1983

Web Traffic

Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
114
Mobile apps
43
Downloads (30d)
19
Active products
40
Patents granted
3,002
Trademarks
384
Top patent class
Medical Or Veterinary Science; Hygiene
IT spend
$797.62M

Investor Activity

Investments
19
Lead investments
7
Portfolio orgs
16
Diversity investments
7
Exits
11
Exits via IPO
10

Company Info

Founded
1980
Employees
10001+
Operating status
Active
Company type
For Profit
Org types
company, investor
Founders
1
Sub-organizations
3
News articles
3,693
Events
10
HQ
Thousand Oaks, California, United States
Region
Greater Los Angeles Area, West Coast, Western US
Exit date
Jun 17, 1983

Signals & Scores

Heat score
High
Growth score
Low
Trend (7d)
-0.1
Trend (30d)
-0.9
Trend (90d)
0
Last leadership hire
Aug 1, 2026
Last layoff mention
Mar 10, 2026

Amgen Funding Rounds

1 results
Upgrade to Pro to view this datasetUpgrade
Organization NameFunding TypeLead Investor NamesInvestor NamesFunding StageOrg IndustriesOrg Hq CityOrg Hq CountryOrg DescriptionOrg Number Of EmployeesOrg Website
1–1 of 1Show
Page 1 / 1

Amgen Investments

Loading columns…
0 of 0Show
Page 1 / 1

Amgen Acquisitions

26 results
Acquiree NameAcquirer NameAcquisition TypeAcquisition TermsAcquiree IndustriesAcquiree Hq CityAcquiree Hq CountryAcquiree DescriptionAcquiree Number Of EmployeesAcquirer IndustriesAcquirer Hq CountryAcquirer Number Of EmployeesAcquirer Ipo StatusAcquiree Website
Dark Blue Therapeutics$840M2026-01-06AmgenAcquisition—BiotechnologyMedicalPharmaceuticalOxfordUnited KingdomDark Blue Therapeutics develops oncology medicines targeting…2020-01-0111-50BiotechnologyHealth CareManufacturingPharmaceuticalUnited States10001+Public26www.darkbluetx.com
Horizon Pharma$27.8B2022-12-12AmgenAcquisitionCashBiopharmaBiotechnologyHealth CareLife ScienceMedicalPharmaceuticalTherapeuticsNorthbrookUnited StatesHorizon Therapeutics focuses on the development of prescript…2005-01-011001-5000BiotechnologyHealth CareManufacturingPharmaceuticalUnited States10001+Public26www.horizontherapeutics.com
ChemoCentryx$3.7B2022-08-04AmgenAcquisitionCashBiotechnologyHealth CareMedical DeviceSan CarlosUnited StatesChemoCentryx is a biopharmaceutical company that develops me…1997-01-01101-250BiotechnologyHealth CareManufacturingPharmaceuticalUnited States10001+Public26www.chemocentryx.com
TeneoBio$900M2021-07-27AmgenAcquisitionCashBiotechnologyHealth CarePharmaceuticalNewarkUnited StatesTeneoBio is a biotechnology company that specializes in the …2009-01-011-10BiotechnologyHealth CareManufacturingPharmaceuticalUnited States10001+Public26www.teneobio.com/
Rodeo Therapeutics$55M2021-03-30AmgenAcquisition—BiotechnologyPharmaceuticalTherapeuticsSeattleUnited StatesRodeo Therapeutics is a developer of small-molecule therapie…2017-01-011-10BiotechnologyHealth CareManufacturingPharmaceuticalUnited States10001+Public26rodeotherapeutics.com/
1–5 of 26Show
Page 1 / 6

Amgen Key People

Chief Executive Officer
Executive Vice President of RandD, and Chief Scientific Officer
Board of Director
Field Director East - Neuroscience
Board of Director
Director Process Development
Board of Director
Global Strategic Sourcing Category Senior Manager
Director of Product Management
Scientific Director
Country Director
Executive Vice President Human Resources
Global Development Lead
Regulatory Strategic Innovation Leader
Executive Director, R&D & CMC Operations
Director of Commercial Information Management
Chief Technology Officer
Senior Vice President and CIO
Senior Manager, Biosimilars Tender & Contracting
Vice President, Global Development Operations
Executive Director
Senior Software Engineer
SVP, General Counsel and Secretary
Vice President External Operations
5,271
professional contacts at Amgen
Contact execs at Amgen →

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions
Bulk Dataset Export

Need the data in bulk? Buy the entire dataset.

5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools

Delivered as CSV, JSON or Parquet — at startup-friendly pricing.

See bulk export

Recent News related to Amgen

Loading news…

FAQs about Amgen

People who checked this page also checked these

Sectors Amgen invests & acquires in

BiotechnologyHealth CarePharmaceuticalMedicalTherapeutics

M&A by year

202620252024202320222021
Browse the full Acquirezy directory.